Calif. Justices To Review Gilead's HIV Drug Negligence Fight

By Dorothy Atkins · May 2, 2024, 6:43 PM EDT

The California Supreme Court has granted Gilead Sciences Inc.'s request to review an appellate court's holding that the drugmaker must face claims it held back a safer HIV drug to maximize profits on...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

Holley et al v. Gilead Sciences, Inc.

Case Number

Court

California Northern

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Date Filed

November 16, 2018

Recent Articles By Dorothy

May 01, 2024
J&J Unit Cuts Deal To End Cancer Drug Trade Secret Fight
February 28, 2024
AdaptHealth, Ex-CEO Cut $51M Deal To End Investor Fight
January 24, 2024
US News Sues SF City Atty Over 'Best Hospitals' Probe
January 12, 2024
Feds Seek Prison Time For Ex-NBA Player In Health Fraud Suit
January 10, 2024
Judge Axes Bellwether Cases In 'Frankenstein' BCBS Fight
January 08, 2024
Walgreens, Humana Cut $360M Deal Ending Crowell Fight
November 07, 2023
Yelp Claims Paxton's Anti-Abortion Center Fight Chills Speech
November 03, 2023
Unsealed FTC Suit Claims 'Staggering' Tracking By Kochava
October 18, 2023
Trans Adults, Minors Get Class Cert. In Fla. Health Care Fight
October 02, 2023
Sutter Health Emails Reveal Billing Confusion In $519M Trial